(Q43807623)

27 November 2017

title

Fluorescence-labeled immunomicelles: preparation, in vivo biodistribution, and ability to cross the blood-brain barrier (English)

1 reference

27 November 2017

1 reference

5

1 reference

27 November 2017

7

Xiabin Jing

1 reference

27 November 2017

6

Yubin Huang

1 reference

27 November 2017

Jun Yue

1

1 reference

27 November 2017

Shi Liu

series ordinal

2

1 reference

27 November 2017

Rui Wang

series ordinal

3

1 reference

27 November 2017

Xiuli Hu

series ordinal

4

1 reference

27 November 2017

publication date

13 July 2012

1 reference

Macromolecular Bioscience

27 November 2017

published in

1 reference

27 November 2017

volume

12

1 reference

27 November 2017

issue

9

1 reference

27 November 2017

page(s)

1209-1219

1 reference

The blood-brain barrier and cancer: transporters, treatment, and Trojan horses

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

The choroid plexuses and the barriers between the blood and the cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Blood-brain barrier: structural components and function under physiologic and pathologic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Drug targeting to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

The role of membrane transporters in drug delivery to brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Shuttle-mediated drug delivery to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Blood-brain barrier transport of therapeutics via receptor-mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Expression and clinical significance of multidrug resistance proteins in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Drug efflux transporters in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Intra-arterial carboplatin chemotherapy for brain tumors: a dose escalation study based on cerebral blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

The effect of graded hypertonic intracarotid infusions on drug delivery to experimental RG-2 gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Nanotechnology in drug delivery and tissue engineering: from discovery to applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Engineering nanocomposite materials for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Nanoparticle therapeutics: an emerging treatment modality for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Active targeting of brain tumors using nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

N-methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Quaternary ammonium beta-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

By-passing of P-glycoprotein using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Folate-decorated succinylchitosan nanoparticles conjugated with doxorubicin for targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Targeting glioma cells in vitro with ascorbate-conjugated pharmaceutical nanocarriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Brain drug delivery of small molecules using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Synthesis of pegylated immunonanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Transferrin receptor on endothelium of brain capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Addition of sulfhydryl groups of Escherichia coli ribosomes by protein modification with 2-iminothiolane (methyl 4-mercaptobutyrimidate)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Antisense imaging of gene expression in the brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Transferrin: structure, function and potential therapeutic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Mechanisms of phagocytosis in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

Self-Assembly Strategy for the Preparation of Polymer-Based Nanoparticles for Drug and Gene Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200037

21 January 2018

Identifiers

DOI

10.1002/MABI.201200037

1 reference

27 November 2017

1 reference